(Q51896431)

English

Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis.

scientific article published in January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

phase III clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

Alexandra Boer Kimball

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Dennis A Revicki

1

object named as

Dennis A Revicki

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Mary Kaye Willian

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Alan Menter

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Kenneth B Gordon

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Craig L Leonardi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Richard G Langley

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Miriam Kimel

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Martin Okun

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Journal of Dermatological Treatment

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

341-350

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Quality of life assessments in dermatology

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

The impact of psoriasis on psychosocial life domains. A review

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

A randomized trial of etanercept as monotherapy for psoriasis.

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

10 years experience of the Dermatology Life Quality Index (DLQI).

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139].

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

The burden of psoriasis: a study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms.

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Responsiveness and minimal important differences for patient reported outcomes

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646172

21 January 2018

Identifiers

10.1080/09546630701646172

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18058494%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51896431&oldid=2152126954"